FDA Approves New Biosimilars to Denosumab with an Interchangeable Designation
The FDA has approved the first interchangeable biosimilars for denosumab.
Source: The Rheumatologist - Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Biologics/DMARDs Conditions Drug Updates Osteoarthritis and Bone Disorders denosumab denosumab-bbdz Jubbonti Prolia Wyost Xgeva Source Type: research